Taro Settles With Texas For $19.5M Over Medicaid Claims
The state of Texas has reached a $19.5 million settlement with Taro Pharmaceuticals USA Inc. to resolve allegations that the drug company fraudulently reported inflated drug prices to the Medicaid program,...To view the full article, register now.
Already a subscriber? Click here to view full article